Rebecca Robbins

Rebecca Robbins

@RebeccaDRobbins

Followers23K
Following10.5K

@nytimes reporter covering the pharmaceutical industry. 714-478-4224 for calls, texts, Signal, & WhatsApp. rebecca.robbins@nytimes.com

Joined on September 05, 2011
@RebeccaDRobbins Statistics

We looked inside some of the tweets by @RebeccaDRobbins and found useful information for you.

Inside 100 Tweets

Time between tweets:
14 hours
Average replies
55
Average retweets
144
Average likes
340
Tweets with photos
5 / 100
Tweets with videos
0 / 100
Tweets with links
0 / 100
Fun Fact

31% of the average smartphone owner's Internet time is spent social networking – close to twice as much as email.

An update on #covid19 monoclonal antibody distribution, via HHS: — 993,000 doses shipped to 6,007 sites, as of 6/16 — 533,000 doses reported used since 12/9/20 (a relatively small # of add'l doses may have been used before then) — 54% of distributed supply used (thru 6/2/2021)

1
10
18

This farewell piece embodies all that I have long admired in @nytDeniseGrady -- beautiful writing, precise and compassionate reporting, and never losing sight of her responsibility to readers or to those who shared their stories. We will miss you, Denise! https://t.co/s5igpyN9fD

1
10
30

Good story from @noahweiland on how the one-and-done $JNJ vaccine became a disappointment: https://t.co/BPZFsiXslj

1
5
11

Is there a pill we could take to cure Covid-19? The US government is setting up a $3.2 billion program to find out. Here’s my @nytimes story on a major new initiative and why the search for a covid antiviral has been disappointing till now. https://t.co/zEILbycWcW

138
197
389

Ouch. CureVac reports an efficacy of just 47 percent against Covid-19 in a preliminary analysis of their Phase 3 trial. Here’s my @nytimes story https://t.co/fTL3qtMkle

29
195
387

Get ready for your Covid-19 booster shot! (Maybe.) Biden administration is buying 200M more doses of Moderna vaccine, with the option to purchase new formulations designed as boosters or pediatric doses. It's not clear whether boosters will be needed. https://t.co/x3O2Bs6ozq

1
11
26

Hahn joins Flagship, press release. https://t.co/PEDc3OdTVY

2
6
14

As the debate over the virus origins raged last week, I picked up the phone & called the Wuhan scientist at the center of the lab leak theories. To my surprise, she picked up. More on what Dr. Shi Zhengli, the "Bat Woman," had to say in our profile. https://t.co/1ERbG759fY

754
1K
3K

Novavax’s big US-Mexico trial confirmed their protein vaccine works well, with 90 percent efficacy. It’s late for the US, but not for the world. And it might prove a good booster too. Here is my story for @nytimes https://t.co/YGvfB5QZd7

26
273
993

1/ MY LATEST: How private equity conquered the US tax system: IRS virtually never audits a $4.5 trillion industry. With @dannyhakim (THREAD) https://t.co/eckvbBniEy

56
837
2K

Scoop: The FDA determined that about 60 million J&J doses made at Emergent BioSolutions can't be used because of contamination risk. The agency plans to allow 10 million doses to be used with a warning about the plant's manufacturing practices. https://t.co/O3g5WrFMAW

1
12
12

The FDA's approval of $BIIB's Aduhelm is spurring major backlash in the scientific community — most notably, with the resignations of 3 advisers to the agency. The question now is whether lawmakers, payers and patients will balk. With @PamBelluck: https://t.co/DSzzLiNBtG

10
44
82

The Biden administration plans to send 500 million doses of Pfizer's coronavirus vaccine to other countries over the next two years w/ @SharonLNYT @SherylNYT https://t.co/RUHJpkQNVv

3
6
10

Quoted @steveubl

This isn’t the first time we’ve heard alarmist predictions about spending on new medicines that were off base. Wildly off base at times. Other dire warnings have missed the mark by an average of 550%. https://t.co/dLj8B73KsA

PhRMA CEO pushing back on critcism related to $BIIB approval and pricing. One thing to note is use of word "cure" in 2nd tweet -- the current drug has so far not proven to be anything close to a cure. https://t.co/31gUjFXfzj

3
6
17

The Medicare Part B program’s total drug spending was $37 billion in 2019 — roughly equivalent to the budget needed treat only about a third of Americans with mild cognitive problems with Aduhelm. https://t.co/FhVC4JP54s

3
14
32

"A therapy of this cost is going to have enormous implications for everyone. And by everyone, I literally mean you, too. There’s going to be some 60 & 70 yos on your plan. If they start getting this treatment, you will see your premiums go up.” -@jsross119 https://t.co/FhVC4JP54s

1
4
10

What makes Alpha so…alpha? A new study suggests one element of the variant’s success: it stuns our defenses with a lot of extra viral proteins. Here’s my story https://t.co/y6ms3BXVbX

3
45
123
Biogen’s stock is halted on FDA decision but check out shares of Eli Lilly, which has an Alzheimer’s drug in development behind it: https://t.co/fyzRpQl7ft

Biogen’s stock is halted on FDA decision but check out shares of Eli Lilly, which has an Alzheimer’s drug in development behind it: https://t.co/fyzRpQl7ft

The FDA just announced that it has approved $BIIB's controversial Alzheimer's drug under the accelerated approval pathway. https://t.co/i73FaxDNH1 Here's our story, via @PamBelluck: https://t.co/ITD8ZCTTwy

1
1
6
Next Page